Roche

DailySand tracks Roche across AI, semiconductor infrastructure, capital markets, and critical minerals supply chains. Below are curated source items and daily digests where Roche appears in today's cross-sector intelligence briefing.

2 items across 2 digests

Related Daily Digests

After Samsung's Strike: How 30,000 Workers Could Reshape AI Chip Supply

April 23, 2026

Behind Marvell's 20% Surge: A $115 Million Copper Bet and the Hidden Cost of AI's Power Hunger

March 6, 2026

All Items

FinancialCNBC Tech

Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment

Roche CEO cited Swiss franc strength as weighing on the drugmaker's first-quarter earnings while doubling down on U.S. investment. Currency headwinds are prompting increased U.S. manufacturing investment to reduce foreign exchange exposure.

#Roche #Swiss franc #currency effects

Read original →

FinancialCNBC Tech

Zealand's stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the 'weight loss Olympics'

Zealand's stock plummeted 35% after their joint drug with Roche showed disappointing 10.7% weight loss results in mid-stage trials. CEO downplays competitive comparisons amid intense competition in the weight-loss drug market.

#Zealand #Roche #weight loss drugs

Read original →